ConductScience.org, home

Paper3910312

Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.

Krettli AU and 1 other. Clin Exp Immunol, 1985. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade. Papers, record 3910312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3910312

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Krettli AUA U
2Pontes de Carvalho LCL C

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement C3Major topic
Trypanosoma cruziMajor topic
Agglutination Tests
Cell Membrane
Complement C3b
Complement Pathway, Alternative
Receptors, Complement
Rosette Formation
Trypsin
Zymosan

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
146840Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.Infect Immun1975https://conductscience.org/library/papers/46840PubMed
26177820Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.J Exp Med1982https://conductscience.org/library/papers/6177820PubMed
3815433Protective effects of specific antibodies in Trypanosoma cruzi infections.J Immunol1976https://conductscience.org/library/papers/815433PubMed
4775012Trypanosoma cruzi: mechanism of entry and intracellular fate in mammalian cells.J Exp Med1976https://conductscience.org/library/papers/775012PubMed
596243Tissue tropism of different Trypanosoma cruzi strains.J Parasitol1978https://conductscience.org/library/papers/96243PubMed
697230Induction of capping in blood-stage trypomastigotes of Trypanosoma cruzi by human anti-Trypanosoma cruzi antibodies.Infect Immun1978https://conductscience.org/library/papers/97230PubMed
7353218Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity.J Exp Med1978https://conductscience.org/library/papers/353218PubMed
831774The in vitro interaction of Trypanosoma cruzi bloodstream forms and mouse peritoneal macrophages.Acta Trop1978https://conductscience.org/library/papers/31774PubMed
9116784Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.Clin Exp Immunol1979https://conductscience.org/library/papers/116784PubMed
106995556Trypanosoma cruzi. Factors modifying ingestion and fate of blood form trypomastigotes.J Exp Med1980https://conductscience.org/library/papers/6995556PubMed
116159781Immunity to Trypanosoma cruzi.Adv Parasitol1980https://conductscience.org/library/papers/6159781PubMed
126454138Enzymatic treatment transforms trypomastigotes of Trypanosoma cruzi into activators of alternative complement pathway and potentiates their uptake by macrophages.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6454138PubMed
137033434Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae.J Exp Med1981https://conductscience.org/library/papers/7033434PubMed
146801127Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.J Immunol1982https://conductscience.org/library/papers/6801127PubMed
156175966Specific glycoprotein antigens on the surface of insect and mammalian stages of Trypanosoma cruzi.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6175966PubMed
166810519Effect of specific chemotherapy on the levels of lytic antibodies in Chagas's disease.Trans R Soc Trop Med Hyg1982https://conductscience.org/library/papers/6810519PubMed
1714110094[MORPHOLOGICAL VARIATIONS OBSERVED IN DIFFERENT STRAINS OF TRYPANOSOMA CRUZI].Rev Inst Med Trop Sao Paulo1963https://conductscience.org/library/papers/14110094PubMed
18807672Studies on the selective lysis and purification of Trypanosoma cruzi.J Exp Med1975https://conductscience.org/library/papers/807672PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
20300530Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.PLoS One2010https://conductscience.org/library/papers/20300530PubMed
12965912Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment.Clin Diagn Lab Immunol2003https://conductscience.org/library/papers/12965912PubMed
7559953Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.J Clin Microbiol1995https://conductscience.org/library/papers/7559953PubMed
3653986Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.Infect Immun1987https://conductscience.org/library/papers/3653986PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
C3718PubTator's text mininghttps://conductscience.org/library/genes/718

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3910312

GET https://conductscience.org/api/papers/v1/3910312/authors